The present invention relates to the use of a starch nanoparticle loaded with at least one active molecule of interest to feed zooplankton, in particular a living prey chosen from rotifers, brine shrimp and copepods. In particular, the invention relates to the use of this loaded starch nanoparticle to increase the size and/or density and/or egg-laying rate of this zooplankton, and/or the hatching rate of the eggs thereof

The disclosure relates to isolated microorganisms—including novel strains of the microorganisms—microbial ensembles, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial compositions, and compositions comprising the same, in methods for treating or preventing gastrointestinal enteropathy or dysbiosis in canines. In particular aspects, the disclosure provides methods of treating or preventing morbidity and mortality caused by GI pathogenesis or autoimmunity.

The disclosure relates to isolated microorganisms—including novel strains of the microorganisms—microbial ensembles, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial compositions, and compositions comprising the same, in methods for treating or preventing gastrointestinal enteropathy or dysbiosis in canines. In particular aspects, the disclosure provides methods of treating or preventing morbidity and mortality caused by GI pathogenesis or autoimmunity.

The present invention relates generally to a feed supplement preparation for administration to ruminant animals and, more particularly, to a formulation for an oral bovine supplement for neonatal calves that delivers naturally occurring caffeine, in a stable liquid form of elevated viscosity and optionally antioxidants and other electrolytes. A 10-40 ml liquid dose of the supplement containing green tea extract delivers a concentrated amount of caffeine of about 100-400 mg to the neonatal calf.

The present disclosure provides an animal food composition comprising a source of glycyrrhizin, in combination with a source of curcuminoids, for use for preventing and/or treating allergic inflammatory skin diseases.

The present disclosure provides an animal food composition comprising a source of glycyrrhizin, in combination with a source of curcuminoids, for use for preventing and/or treating allergic inflammatory skin diseases.

A container for storing an aqueous composition for a domestic animal is provided herein. The container includes a shell having base and a wall extending distally from the base to a lip. The shell defines a chamber between the base and the lip. The container further includes a lid. The lid is configured to cooperate with the lip for removably coupling the lid and the shell. The container further includes an aqueous composition disposed within the chamber. The shell and the lid exhibit a water vapor transmission rate of less than 100,000 g/m.sup.2/24 hours in accordance with ASTM D6701-16.

A container for storing an aqueous composition for a domestic animal is provided herein. The container includes a shell having base and a wall extending distally from the base to a lip. The shell defines a chamber between the base and the lip. The container further includes a lid. The lid is configured to cooperate with the lip for removably coupling the lid and the shell. The container further includes an aqueous composition disposed within the chamber. The shell and the lid exhibit a water vapor transmission rate of less than 100,000 g/m.sup.2/24 hours in accordance with ASTM D6701-16.

Described are compositions comprising one or more nutrients encapsulated in a controlled release lipid matrix for feeding an animal.

Described are compositions comprising one or more nutrients encapsulated in a controlled release lipid matrix for feeding an animal.